Prevention and Control of Methicillin-Resistant Staphylococcus aureus in Acute Care Settings

被引：14
|
作者：
Lee, Andie S. [1 ,2 ]
Huttner, Benedikt [3 ,4 ]
Harbarth, Stephan [3 ]
机构：
[1] Royal Prince Alfred Hosp, Dept Infect Dis, Missenden Rd, Sydney, NSW 2050, Australia
[2] Royal Prince Alfred Hosp, Dept Microbiol, Missenden Rd, Sydney, NSW 2050, Australia
[3] Univ Hosp Geneva, Infect Control Programme, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland
[4] Univ Hosp Geneva, Div Infect Dis, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland
来源：
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2016年 / 30卷 / 04期
关键词：
Methicillin-resistant Staphylococcus aureus; MRSA; Epidemiology; Infection prevention; Infection control; Active surveillance cultures; Screening; Decolonization; SURGICAL-SITE INFECTIONS; INTERRUPTED TIME-SERIES; IMPROVED HAND HYGIENE; ENVIRONMENTAL CLEANING INTERVENTION; CLOSTRIDIUM-DIFFICILE INFECTION; HOSPITAL-ACQUIRED INFECTIONS; RANDOMIZED CONTROLLED-TRIAL; INTENSIVE-CARE; ANTIBIOTIC STEWARDSHIP; SURVEILLANCE CULTURES;
D O I：
10.1016/j.idc.2016.07.006
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of health care associated infections worldwide. Controversies with regard to the effectiveness of various MRSA control strategies have contributed to varying approaches to the control of this pathogen in different settings. However, new evidence from large-scale studies has emerged, particularly with regards to MRSA screening and decolonization strategies, which will inform future control practices. The implementation as well as outcomes of control measures in the real world is not only influenced by scientific evidence but also depends on economic, administrative, governmental, and political influences.
引用
收藏
页码：931 / +
页数：23
相关论文
共 50 条
  • [1] Methicillin-Resistant Staphylococcus aureus: An Update on Prevention and Control in Acute Care Settings
    Lee, Andie S.
    Huttner, Benedikt D.
    Catho, Gaud
    Harbarth, Stephan
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2021, 35 (04) : 931 - 952
  • [2] Prevention and Control of Methicillin-Resistant Staphylococcus aureus
    Gleeson, Todd D.
    DM DISEASE-A-MONTH, 2008, 54 (12): : 801 - 806
  • [3] Prevention and control of methicillin-resistant Staphylococcus aureus
    Humphreys, H.
    Grundmann, H.
    Skov, R.
    Lucet, J-C.
    Cauda, R.
    CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (02) : 120 - 124
  • [4] Prevention and control of methicillin-resistant Staphylococcus aureus infections
    Farr, BM
    CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (04) : 317 - 322
  • [5] Methicillin-resistant staphylococcus aureus in athletic settings
    Buckley, Bernadette D.
    Beam, Joel W.
    ATHLETIC THERAPY TODAY, 2007, 12 (06): : 20 - 23
  • [6] STAKEHOLDER PERSPECTIVE Prevention and Control of Methicillin-Resistant Staphylococcus aureus
    Perrotta, Dennis M.
    AMERICAN HEALTH AND DRUG BENEFITS, 2009, 2 (02): : 95 - 95
  • [7] Infections with methicillin-resistant Staphylococcus aureus. Prevention and control
    Dresbach, T.
    Mueller, A.
    Simon, A.
    MONATSSCHRIFT KINDERHEILKUNDE, 2015, 163 (05) : 437 - 447
  • [8] Control of methicillin-resistant Staphylococcus aureus
    Sheppard, MJ
    JOURNAL OF HOSPITAL INFECTION, 1996, 32 (01) : 73 - 75
  • [9] Control of Methicillin-resistant Staphylococcus aureus
    Lee, Andie S.
    Huttner, Benedikt
    Harbarth, Stephan
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2011, 25 (01) : 155 - +
  • [10] Optimal control of methicillin-resistant Staphylococcus aureus transmission in hospital settings
    Agusto, F. B.
    APPLIED MATHEMATICAL MODELLING, 2016, 40 (7-8) : 4822 - 4843
12345